Business Description
![DexCom Inc DexCom Inc logo](https://static.gurufocus.com/logos/0C00000AXT.png?14)
DexCom Inc
NAICS : 325413
SIC : 5047
ISIN : US2521311074
Share Class Description:
XTER:DC4: Ordinary SharesCompare
Compare
Traded in other countries / regions
DXCM.USA0A4M.UKDC4.GermanyD1EX34.BrazilDXCM.MexicoDXCM.Austria Description
Dexcom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery.
Financial Strength
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 1.12 | |||||
Equity-to-Asset | 0.35 | |||||
Debt-to-Equity | 1.15 | |||||
Debt-to-EBITDA | 2.6 | |||||
Interest Coverage | 32.1 | |||||
Piotroski F-Score | 7/9 | |||||
Altman Z-Score | 8.34 | |||||
Beneish M-Score | -2.21 | |||||
WACC vs ROIC |
Growth Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 19.9 | |||||
3-Year EBITDA Growth Rate | 30.6 | |||||
3-Year EPS without NRI Growth Rate | 0.6 | |||||
3-Year FCF Growth Rate | 19.3 | |||||
3-Year Book Growth Rate | 4.1 | |||||
Future 3-5Y EPS without NRI Growth Rate | 18.05 | |||||
Future 3-5Y Total Revenue Growth Rate | 19.53 |
Momentum Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 43.81 | |||||
9-Day RSI | 39.63 | |||||
14-Day RSI | 39.16 | |||||
6-1 Month Momentum % | 1.12 | |||||
12-1 Month Momentum % | -2.85 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 2.9 | |||||
Quick Ratio | 2.53 | |||||
Cash Ratio | 1.82 | |||||
Days Inventory | 125.72 | |||||
Days Sales Outstanding | 79.22 | |||||
Days Payable | 68.36 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -0.1 | |||||
Shareholder Yield % | -1.12 |
Profitability Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 62.82 | |||||
Operating Margin % | 17.14 | |||||
Net Margin % | 16.82 | |||||
FCF Margin % | 15.39 | |||||
ROE % | 29.28 | |||||
ROA % | 10.09 | |||||
ROIC % | 23.26 | |||||
ROC (Joel Greenblatt) % | 63.18 | |||||
ROCE % | 17.43 | |||||
Years of Profitability over Past 10-Year | 5 |
GF Value Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 74.81 | |||||
Forward PE Ratio | 63.69 | |||||
PE Ratio without NRI | 77.82 | |||||
Shiller PE Ratio | 306.75 | |||||
Price-to-Owner-Earnings | 94.89 | |||||
PS Ratio | 12.89 | |||||
PB Ratio | 20.44 | |||||
Price-to-Tangible-Book | 21.87 | |||||
Price-to-Free-Cash-Flow | 84.27 | |||||
Price-to-Operating-Cash-Flow | 61.22 | |||||
EV-to-EBIT | 57.35 | |||||
EV-to-Forward-EBIT | 57.6 | |||||
EV-to-EBITDA | 46.01 | |||||
EV-to-Forward-EBITDA | 41.49 | |||||
EV-to-Revenue | 12.05 | |||||
EV-to-Forward-Revenue | 10.58 | |||||
EV-to-FCF | 78.5 | |||||
Price-to-Projected-FCF | 9.05 | |||||
Price-to-Median-PS-Value | 0.84 | |||||
Price-to-Graham-Number | 8.7 | |||||
Price-to-Net-Current-Asset-Value | 119.54 | |||||
Earnings Yield (Greenblatt) % | 1.74 | |||||
FCF Yield % | 1.27 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
DexCom Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 3,513.741 | ||
EPS (TTM) (€) | 1.43 | ||
Beta | 1.72 | ||
Volatility % | 43.88 | ||
14-Day RSI | 39.16 | ||
14-Day ATR (€) | 2.268077 | ||
20-Day SMA (€) | 112.925 | ||
12-1 Month Momentum % | -2.85 | ||
52-Week Range (€) | 71.47 - 131.78 | ||
Shares Outstanding (Mil) | 397.68 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 7 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
DexCom Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
DexCom Inc Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
DexCom Inc Frequently Asked Questions
What is DexCom Inc(XTER:DC4)'s stock price today?
The current price of XTER:DC4 is €107.76. The 52 week high of XTER:DC4 is €131.78 and 52 week low is €71.47.
When is next earnings date of DexCom Inc(XTER:DC4)?
The next earnings date of DexCom Inc(XTER:DC4) is 2024-07-26 Est..
Does DexCom Inc(XTER:DC4) pay dividends? If so, how much?
DexCom Inc(XTER:DC4) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |